LabCorp, Ciox Health to create COVID-19 patient database

By staff writers

April 9, 2020 -- LabCorp and health information management company Ciox Health have announced a partnership to create a patient data registry to help researchers address the ongoing COVID-19 pandemic.

The U.S.-based registry will include curated, HIPAA-compliant data of patients infected by the novel coronavirus. The goal is to expedite critical COVID-19 research and analysis for diagnosis, treatment, and future pandemic prevention efforts.

The registry will be the first of its kind, according to LabCorp and Ciox Health. It will initially use deidentified patient data from LabCorp's diagnostic datasets. So far, the company has completed about 500,000 tests since its COVID-19 diagnostic tests launched on March 5.

It's time to recruit research labs in the COVID-19 fight
Careful incorporation of research laboratories into the COVID-19 testing effort could increase capacity in the U.S. and globally, writes molecular diagnostics...
WHO selects Roche, Primerdesign coronavirus tests for emergency use
Molecular tests by Primerdesign and Roche are the first two to get emergency use listing by the World Health Organization (WHO) for SARS-CoV-2, paving...
U.K. offers update on COVID-19 testing plan
The U.K. government has provided an update on its plan to work with British industry to rapidly ramp up testing for COVID-19 in the country.
CMS delivers $34B in accelerated COVID-19 payments
The U.S. Centers for Medicare and Medicaid Services (CMS) delivered approximately $34 billion in one week from the Accelerated and Advance Payment...
LabCorp launches novel coronavirus test
LabCorp has released a nucleic acid amplification test for detecting the presence of SARS-CoV-2, the virus that causes COVID-19.

Copyright © 2020

Last Updated np 4/9/2020 3:35:06 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current